The AngelMed Guardian® system is an implantable cardiac device, designed to detect rapid ST segment changes - ST shifts - that may signify major cardiac events, such as coronary artery occlusions caused by life-threatening vulnerable plaque ruptures. Once an ST shift is detected, the system is designed to alert patients to seek medical care by delivering a series of vibratory, auditory, and visual warnings.
The AngelMed Guardian system is intended to address the challenge of patients not recognizing nor responding quickly to heart attacks. The system, currently commercially available in Brazil, is the subject of a phase-II clinical study in the US: ALERTS.
The AngelMed Guardian System is designed to detect and then alert patients to the early warning signs that may indicate a serious ischemic event. Note that the system has not yet been proven to perform these functions.